Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

The Razin Group Issues Presentation Detailing the Need to Reset the Balance of Power in NextGen Healthcare’s Dysfunctional and Insular Boardroom

Highlights the Company’s Anti-Shareholder Governance, Failed Acquisitions Strategy, Poor Operating Results and Persistent Share Price Underperformance During the Six-Year Chairmanship of Jeffrey Margolis

Outlines the Onerous Terms of the Company’s Proposed Delaware Reincorporation, Which Would Strengthen the Margolis Board’s Power and Weaken Shareholders’ Rights

Opposes the Reelection of Mr. Margolis and Three Entrenched Directors, Who Have Each Held Committee Chair Roles During a Lengthy Period of Stagnation and Underperformance

Urges Shareholders to Vote on the BLUE Proxy Card to Elect the Razin Group’s Minority Slate, Which Possesses a Vision for Improving Governance and Prioritizing Value Creation

Sheldon Razin, who collectively with Lance Rosenzweig and the other participants in his solicitation (collectively, the “Razin Group”) owns approximately 15.2% of the outstanding common shares of NextGen Healthcare, Inc. (NASDAQ: NXGN) (“NextGen Healthcare” or the “Company”), today issued a 70-page presentation that details the case for resetting the balance of power on NextGen Healthcare's nine-member Board of Directors (the "Board"). The Razin Group urges shareholders to vote on the BLUE Proxy Card to elect its four-member slate, which includes Kenneth H. Fearn, Messrs. Razin and Rosenzweig and Ruby Sharma. Please visit www.FixNextGen.com to download the Razin Group slate’s presentation and obtain important information about our value-enhancing vision.

Messrs. Razin and Rosenzweig commented:

"This election contest is about resetting the balance of power in NextGen Healthcare's dysfunctional and insular boardroom in order to ensure that shareholders' best interests are prioritized following six years of anemic revenue growth, deteriorating earnings, dismal capital allocation, poor governance and sustained share price underperformance. We contend that the Company has taken a massive step backward during the past six years under the reign of Chairman Jeffrey Margolis and his fellow Board leaders, Craig Barbarosh, George Bristol and Morris Panner. Their consistent disregard for the Company’s shareholders was mostly recently evidenced by the decision to propose an onerous Delaware reincorporation that would strengthen the Margolis Board’s power while taking away shareholders’ rights, such as the right to fill director vacancies and the right to act by written consent. We believe our minority slate possesses the constructive mindset and relevant skills needed to work with the remaining incumbents to fix the Company's troubling governance, non-accretive capital allocation policy and failed execution against growth objectives. In our view, the Company’s shareholders have a unique opportunity this year to establish a new culture of accountability, incentivization and innovation as a new CEO joins – to be clear, NextGen Healthcare’s new leadership should not be continuously beholden to Mr. Margolis and his allies."

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.